AI-Powered Biological Software with Jakob Uszkoreit, CEO of Inceptive

"Biological Software" is the future of medicine. Jakob Uszkoreit, CEO and Co-founder of Inceptive, joins Sarah Guo and Elad Gil this week on No Priors, to discuss how deep learning is expanding the horizons of RNA and mRNA therapeutics. Jakob co-authored the revolutionary paper Attention is All You Need while at Google, and led early Google Translate and Google Assistant teams. Now at Inceptive, he's applying these same architectures and ideas to biological design, optimizing vaccine production, and magnitude-more efficient drug discovery. We also discuss Jakob's perspective on promising research directions, and his point of view that model architectures will actually get simpler from here, and be driven by hardware. Show Links:  Inceptive - CEO & Founder - Jakob Uszkoreit | LinkedIn   Inceptive Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @kyosu Show Notes:  (0:00:00) - Creating Biological Software (0:06:54) - The Hardware Drivers of Large-Scale Transformers (0:14:32) - Challenges in Optimizing Compute Allocation (0:23:25) - Deep Learning in Biology and RNA (0:32:49) - The Future of Drug Discovery (0:41:41) - Collaboration and Innovation at Inceptive

Om Podcasten

At this moment of inflection in technology, co-hosts Elad Gil and Sarah Guo talk to the world's leading AI engineers, researchers and founders about the biggest questions: How far away is AGI? What markets are at risk for disruption? How will commerce, culture, and society change? What’s happening in state-of-the-art in research? “No Priors” is your guide to the AI revolution. Email feedback to show@no-priors.com. Sarah Guo is a startup investor and the founder of Conviction, an investment firm purpose-built to serve intelligent software, or "Software 3.0" companies. She spent nearly a decade incubating and investing at venture firm Greylock Partners. Elad Gil is a serial entrepreneur and a startup investor. He was co-founder of Color Health, Mixer Labs (which was acquired by Twitter). He has invested in over 40 companies now worth $1B or more each, and is also author of the High Growth Handbook.